Australian Meningococcal Surveillance Programme, 1 January to 31 March 2017

The Australian Meningococcal Surveillance Programme monitors anticrobial resistance in the treatments for meningococcal infection. This quarterly report describes the results for the 1st quarter of 2017.

Page last updated: 30 June 2017

Monica M Lahra, Rodney P Enriquez for the for the National Neisseria Network, Australia

The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases confirmed by laboratory testing using culture and by non-culture based techniques. Culture positive cases, where Neisseria meningitidis is grown from a normally sterile site or skin lesions, and non-culture based diagnoses, derived from results of nucleic acid amplification assays and serological techniques, are defined as invasive meningococcal disease (IMD) according to Public Health Laboratory Network definitions. Data contained in quarterly reports are restricted to a description of the number of cases by jurisdiction and serogroup, where known. Some minor corrections to data in the Table may be made in subsequent reports if additional data are received. A full analysis of laboratory confirmed cases of IMD in each calendar year is contained in the AMSP annual reports published in Communicable Diseases Intelligence.

Table: Number of laboratory confirmed cases of invasive meningococcal disease, Australia, 1 January to 31 March 2016, by serogroup and state or territory
State or territory Year Serogroup
A B C Y W ND/other All
Q1 YTD Q1 YTD Q1 YTD Q1 YTD Q1 YTD Q1 YTD Q1 YTD
Australian Capital Territory 2017 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2016 0 0 0 0 0 0 0 0 0 0 0 0 0 0
New South Wales 2017 0 0 9 9 2 2 2 2 3 3 0 0 16 16
2016 0 0 5 5 1 1 0 0 4 4 3 3 13 13
Northern Territory 2017 0 0 0 0 0 0 1 1 1 1 0 0 2 2
2016 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Queensland 2017 0 0 12 12 0 0 7 7 3 3 0 0 22 22
2016 0 0 4 4 0 0 4 4 2 2 0 0 10 10
South Australia 2017 0 0 1 1 0 0 2 2 2 2 0 0 5 5
2016 0 0 6 6 0 0 0 0 0 0 0 0 6 6
Tasmania 2017 0 0 1 1 0 0 0 0 4 4 0 0 5 5
2016 0 0 0 0 0 0 0 0 2 2 0 0 2 2
Victoria 2017 0 0 4 4 0 0 4 4 7 7 1 1 16 16
2016 0 0 3 3 1 1 0 0 5 5 0 0 9 9
Western Australia 2017 0 0 3 3 1 1 0 0 4 4 1 1 9 9
2016 0 0 1 1 0 0 0 0 2 2 0 0 3 3
Total 2017 0 0 30 30 3 3 16 16 24 24 2 2 75 75
2016 0 0 19 19 2 2 4 4 15 15 3 3 43 43

Author details

Monica M Lahra1,2

Rodney P Enriquez1

  1. Neisseria Reference Laboratory and World Health Organization Collaborating Centre for STD, Sydney. Department of Microbiology, South Eastern Area Laboratory Services, The Prince of Wales Hospital, Randwick, New South Wales
  2. School of Medical Sciences, Faculty of Medicine, The University of New South Wales, New South Wales

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now